Stop TB and GDF makes global headlines announcing breaking news on Bedaquiline agreement

On July 13 following lengthy negotiations, Johnson granted Stop TB Partnership´s Global Drug Facility`s licenses that enable Global Drug Facility (GDF) to tender, procure, and supply generic versions of SIRTURO® (bedaquiline) for the majority of low-and middle-income countries, including countries where patents remain in effect.

As a result of this breaking news, there was a large media interest which resulted in top-tier media coverage: